BackBioray Biotech , Ltd Overview

Bioray Biotech , Ltd Total Assets

Latest total assets for 7561.TWO: $560M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$564.09M
↑ 7.66% YoYΔ $40.12M vs prior year quarter

Peer trimmed avg / median

Loading

Bioray Biotech , Ltd Total Assets History

Loading

Bioray Biotech , Ltd vs. peers: Total Assets Comparison

Loading

Bioray Biotech , Ltd Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Bioray Biotech , Ltd (7561.TWO) FAQ

As of the most recent data (June 2026), 7561.TWO shows a total assets of $560M. That compares with $520M in the prior-year period — up 7.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 7561.TWO's total assets is now $560M (was $520M) — a 7.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Bioray Biotech , Ltd is outperforming or lagging.

Tracking 7561.TWO's total assets over time shows whether Bioray Biotech , Ltd is scaling, shrinking, or reshaping that part of the business. The current reading is $560M That compares with $520M in the prior-year period — up 7.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Bioray Biotech , Ltd's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $560M) with ownership activity and broader fundamentals.